Mechanistic explorations showed that PRMT5 could regulate tumorigenesis and metastasis of laryngeal carcinoma by activating the Wnt4/β-catenin signaling pathway (Fig. 6f). The gene discussed is PRMT5; the disease is laryngeal carcinoma.